• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内异质性:结直肠癌研究的新视角。

Intratumor heterogeneity: A new perspective on colorectal cancer research.

机构信息

Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.

Tianjin General Surgery Institute, Tianjin, China.

出版信息

Cancer Med. 2020 Oct;9(20):7637-7645. doi: 10.1002/cam4.3323. Epub 2020 Aug 27.

DOI:10.1002/cam4.3323
PMID:32853464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7571807/
Abstract

Colorectal cancers generally consist of multiple subclones. These subclones have their own unique characteristics, resulting in intratumor heterogeneity (ITH). As the discussion of ITH has advanced, a model describing the relationship of ITH to the tumor has gradually emerged. ITH can be divided into two types of intraprimary tumor heterogeneity and intraindividual tumor heterogeneity, the former for further understanding of tumor composition, and the latter for providing more information about evolutionary patterns. With the rapid development of new methods, such as next-generation, polyguanine region sequencing, and Image detection, researchers may unravel the secrets underlying ITH. The higher the ITH of the tumor, the richer the interaction between the subclones maybe, or the greater the chance of the tumor getting more powerful subclones may be, thus increasing the malignant potential of the tumor. Existing evidence suggests that ITH may increase the ability of tumors to resist treatment and can be used as an independent influence on the prognosis of colorectal cancer. We reviewed 80 recent studies to give researchers a new perspective on colorectal cancer. There is still a limited amount of research in this area. Further study of the relationship between ITH and clinical endpoints may lead to the development of new treatment strategies.

摘要

结直肠癌通常由多个亚克隆组成。这些亚克隆具有各自独特的特征,导致肿瘤内异质性(ITH)。随着对 ITH 的讨论不断深入,一种描述 ITH 与肿瘤关系的模型逐渐浮现。ITH 可分为原发性肿瘤内异质性和个体内肿瘤异质性两种类型,前者有助于进一步了解肿瘤的组成,后者则为进化模式提供了更多信息。随着新一代、聚鸟嘌呤区测序和图像检测等新技术的快速发展,研究人员或许能够揭开 ITH 的奥秘。肿瘤的 ITH 越高,亚克隆之间的相互作用可能越丰富,或者肿瘤获得更强大亚克隆的机会可能越大,从而增加肿瘤的恶性潜能。现有证据表明,ITH 可能会增加肿瘤对治疗的抵抗力,并可作为影响结直肠癌预后的独立因素。我们回顾了 80 项最近的研究,为研究人员提供了结直肠癌的新视角。该领域的研究仍然有限。进一步研究 ITH 与临床终点之间的关系可能会促使新的治疗策略的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e958/7571807/149c5aa4bdd7/CAM4-9-7637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e958/7571807/0d74c99418b3/CAM4-9-7637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e958/7571807/149c5aa4bdd7/CAM4-9-7637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e958/7571807/0d74c99418b3/CAM4-9-7637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e958/7571807/149c5aa4bdd7/CAM4-9-7637-g002.jpg

相似文献

1
Intratumor heterogeneity: A new perspective on colorectal cancer research.肿瘤内异质性:结直肠癌研究的新视角。
Cancer Med. 2020 Oct;9(20):7637-7645. doi: 10.1002/cam4.3323. Epub 2020 Aug 27.
2
Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures.结直肠癌肿瘤内遗传异质性的特征分析及匹配的患者来源球体培养物。
Mol Oncol. 2018 Jan;12(1):132-147. doi: 10.1002/1878-0261.12156. Epub 2017 Nov 27.
3
Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.通过整合基因组分析和数学建模来理解肿瘤内异质性。
Cancer Sci. 2018 Apr;109(4):884-892. doi: 10.1111/cas.13510. Epub 2018 Feb 28.
4
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.肿瘤内异质性作为生存预后决定因素的泛癌分析。
Oncotarget. 2016 Mar 1;7(9):10051-63. doi: 10.18632/oncotarget.7067.
5
DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.DITHER:一种基于熵定义肿瘤内异质性的算法。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab202.
6
Intratumor heterogeneity: evolution through space and time.肿瘤内异质性:时空演变。
Cancer Res. 2012 Oct 1;72(19):4875-82. doi: 10.1158/0008-5472.CAN-12-2217. Epub 2012 Sep 20.
7
Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.多区域测序揭示肝癌和结直肠癌肿瘤内异质性和体细胞 mtDNA 突变的正选择。
Int J Cancer. 2018 Sep 1;143(5):1143-1152. doi: 10.1002/ijc.31395. Epub 2018 Apr 16.
8
Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies.口腔肿瘤异质性及其对患者监测和抗癌策略设计的影响。
Pathol Res Pract. 2024 Jan;253:154953. doi: 10.1016/j.prp.2023.154953. Epub 2023 Nov 20.
9
Lymph Node Metastases in Colon Cancer Are Polyclonal.结直肠癌的淋巴结转移呈多克隆性。
Clin Cancer Res. 2018 May 1;24(9):2214-2224. doi: 10.1158/1078-0432.CCR-17-1425. Epub 2017 Dec 4.
10
Many private mutations originate from the first few divisions of a human colorectal adenoma.许多体细胞突变起源于人类结肠直肠腺瘤的最初几次细胞分裂。
J Pathol. 2015 Nov;237(3):355-62. doi: 10.1002/path.4581. Epub 2015 Aug 3.

引用本文的文献

1
A plasma metabolite-based test to detect minimal residual disease in post-surgery patients with colorectal cancer.一种基于血浆代谢物的检测方法,用于检测结直肠癌术后患者的微小残留病。
iScience. 2025 Jul 21;28(9):113138. doi: 10.1016/j.isci.2025.113138. eCollection 2025 Sep 19.
2
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial.在可接受抗表皮生长因子受体(EGFR)再挑战治疗的难治性转移性结直肠癌患者中,通过液体活检进行综合基因组分析:CAVE-2 GOIM试验的结果
ESMO Open. 2025 Jun 23;10(7):105491. doi: 10.1016/j.esmoop.2025.105491.
3

本文引用的文献

1
A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansion.用于可视化致癌克隆扩增功能基因组学的癌症彩虹鼠。
Nat Commun. 2019 Dec 2;10(1):5490. doi: 10.1038/s41467-019-13330-y.
2
The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer-The Impact in Intratumoral Heterogeneity.新辅助放化疗对局部晚期直肠癌的影响——对瘤内异质性的影响
Front Oncol. 2019 Sep 27;9:974. doi: 10.3389/fonc.2019.00974. eCollection 2019.
3
Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer.
Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023.
免疫肿瘤学的机遇与挑战:2014年至2023年的文献计量分析
Hum Vaccin Immunother. 2025 Dec;21(1):2440203. doi: 10.1080/21645515.2024.2440203. Epub 2025 Jan 30.
4
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.从隐窝到癌症:结直肠癌发生和治疗策略的整体观点。
Int J Mol Sci. 2024 Aug 30;25(17):9463. doi: 10.3390/ijms25179463.
5
Dissecting the Mechanisms of Intestinal Immune Homeostasis by Analyzing T-Cell Immune Response in Crohn's Disease and Colorectal Cancer.通过分析克罗恩病和结直肠癌中的 T 细胞免疫应答来剖析肠道免疫稳态的机制。
Curr Gene Ther. 2024;24(5):422-440. doi: 10.2174/0115665232294568240201073417.
6
Editorial: Clinical risk assessment and intervention of gastrointestinal tumors driven by big-data.社论:大数据驱动的胃肠道肿瘤临床风险评估与干预
Front Med (Lausanne). 2024 Feb 27;11:1379762. doi: 10.3389/fmed.2024.1379762. eCollection 2024.
7
Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays.基于血液的循环肿瘤 DNA 检测的临床实践指南。
Ann Lab Med. 2024 May 1;44(3):195-209. doi: 10.3343/alm.2023.0389. Epub 2024 Jan 15.
8
Early Evolution in Cancer: A Mathematical Support for Pathological and Genomic Evidence in Clear Cell Renal Cell Carcinoma.癌症的早期演变:对透明细胞肾细胞癌病理和基因组证据的数学支持
Cancers (Basel). 2023 Dec 18;15(24):5897. doi: 10.3390/cancers15245897.
9
Disruptions in cell fate decisions and transformed enteroendocrine cells drive intestinal tumorigenesis in Drosophila.细胞命运决定的中断和转化的肠内分泌细胞驱动果蝇的肠道肿瘤发生。
Cell Rep. 2023 Nov 28;42(11):113370. doi: 10.1016/j.celrep.2023.113370. Epub 2023 Nov 3.
10
Using picoliter droplet deposition to track clonal competition in adherent and organoid cancer cell cultures.利用皮升级液滴沉积技术追踪贴壁培养和类器官培养中的克隆竞争。
Sci Rep. 2023 Nov 1;13(1):18832. doi: 10.1038/s41598-023-42849-w.
肿瘤浸润淋巴细胞和巨噬细胞可改善微卫星不稳定结直肠癌患者的生存。
Sci Rep. 2019 Sep 17;9(1):13455. doi: 10.1038/s41598-019-49878-4.
4
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma.UVB 诱导的肿瘤异质性降低黑色素瘤的免疫反应。
Cell. 2019 Sep 19;179(1):219-235.e21. doi: 10.1016/j.cell.2019.08.032. Epub 2019 Sep 12.
5
Rectal cancer sub-clones respond differentially to neoadjuvant therapy.直肠癌亚克隆对新辅助治疗的反应存在差异。
Neoplasia. 2019 Oct;21(10):1051-1062. doi: 10.1016/j.neo.2019.08.004. Epub 2019 Sep 12.
6
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy.单细胞转录组学揭示了对内分泌治疗的多步适应。
Nat Commun. 2019 Sep 2;10(1):3840. doi: 10.1038/s41467-019-11721-9.
7
An enhanced genetic model of colorectal cancer progression history.结直肠癌进展史的增强遗传模型。
Genome Biol. 2019 Aug 15;20(1):168. doi: 10.1186/s13059-019-1782-4.
8
Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.由 APOBEC3A 和中尺度基因组特征驱动的癌症中的乘客热点突变。
Science. 2019 Jun 28;364(6447). doi: 10.1126/science.aaw2872.
9
Quantitative evidence for early metastatic seeding in colorectal cancer.结直肠癌早期转移播种的定量证据。
Nat Genet. 2019 Jul;51(7):1113-1122. doi: 10.1038/s41588-019-0423-x. Epub 2019 Jun 17.
10
Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer.单细胞转录组学揭示了肝癌肿瘤内异质性和干性相关亚群的全景。
Cancer Lett. 2019 Sep 10;459:176-185. doi: 10.1016/j.canlet.2019.06.002. Epub 2019 Jun 10.